Theraclion Share Price OTC Markets
Stocks
TCLI.F
FR0010120402
Advanced Medical Equipment & Technology
OTC Markets Traded|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.5320 USD | +66.25% |
|
-.--% | +66.25% |
| 06-19 | Claude Lenoir appointed interim chairman of Theraclion | |
| 06-19 | Theraclion Chairman Steps Down; Interim Successor Named | MT |
| Market Cap | 49.86M 56.76M 45.94M 43.01M 80.58M 5.38B 81.94M 552M 214M 2.64B 213M 208M 9.17B | P/E 2024 |
-2.66x | P/E 2025 | -6.33x |
|---|---|---|---|---|---|
| Enterprise Value | 57.71M 65.69M 53.18M 49.78M 93.27M 6.22B 94.84M 639M 247M 3.05B 247M 241M 10.61B | EV / Sales 2024 |
22.5x | EV / Sales 2025 | 55.4x |
| Free-Float |
54.37% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | +66.25% | ||
| 3 months | +66.25% | ||
| 6 months | +66.25% | ||
| Current year | +66.25% |
| Current year | 0.53 | 0.53 | |
| 1 year | 0.53 | 0.53 | |
| 3 years | 0 | 0.59 | |
| 5 years | 0 | 2.28 | |
| 10 years | 0 | 2.6 |
| Manager | Title | Age | Since |
|---|---|---|---|
Martin Deterre
CEO | Chief Executive Officer | - | 23/05/2023 |
Julie Veisseire
DFI | Director of Finance/CFO | - | - |
Gaylord Tallec
COO | Chief Operating Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Renaud Saleur
BRD | Director/Board Member | - | 31/01/2018 |
Ari Kellen
BRD | Director/Board Member | - | 12/02/2019 |
Shawn Langer
BRD | Director/Board Member | - | 12/02/2019 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +66.25% | -.--% | - | - | 54.3M | ||
| +1.15% | -0.69% | +17.28% | -10.47% | 172B | ||
| +0.06% | -3.33% | -21.73% | +23.20% | 143B | ||
| +0.44% | -1.31% | -8.85% | -24.86% | 126B | ||
| +2.86% | -2.81% | -55.45% | -15.51% | 65.89B | ||
| +1.25% | -1.84% | +15.44% | -3.75% | 49.45B | ||
| +0.06% | -2.21% | -25.84% | -32.63% | 44.05B | ||
| +0.14% | -1.30% | +9.08% | +6.07% | 35.72B | ||
| -0.29% | -0.93% | +4.19% | +37.47% | 35.18B | ||
| +5.08% | +0.77% | -10.46% | -20.17% | 27.58B | ||
| Average | +7.29% | -1.60% | -8.48% | -4.52% | 77.68B | |
| Weighted average by Cap. | +0.55% | -1.98% | -7.27% | -4.71% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 830K 945K 765K 716K 1.34M 89.52M 1.36M 9.19M 3.56M 43.92M 3.55M 3.47M 153M | 652K 742K 601K 562K 1.05M 70.31M 1.07M 7.21M 2.79M 34.5M 2.79M 2.73M 120M |
| Net income | -5.76M -6.55M -5.3M -4.97M -9.3M -621M -9.46M -63.7M -24.66M -305M -24.6M -24.07M -1.06B | -5.69M -6.48M -5.24M -4.91M -9.2M -614M -9.35M -62.95M -24.37M -301M -24.31M -23.79M -1.05B |
| Net Debt | 3.41M 3.88M 3.14M 2.94M 5.51M 368M 5.61M 37.74M 14.61M 180M 14.57M 14.26M 627M | 7.85M 8.94M 7.24M 6.77M 12.69M 847M 12.9M 86.88M 33.63M 415M 33.55M 32.83M 1.44B |
Employees
36
Annual profits - Rate of surprise
- Stock Market
- Stocks
- ALTHE Stock
- TCLI.F Stock
Select your edition
All financial news and data tailored to specific country editions
















